Loading…
Strides Pharma Science (STAR)₹1,002−3.25%Pharmaceuticals
At the end of the Sep 2026 quarter, Strides Pharma Science's shareholders were: promoters 28.96%, FIIs 28.02%, DIIs 15.49%, government 0.01%, public 27.52%. Promoter holding is up 1.09 percentage points from 27.87% a quarter earlier. FII holding is down 0.53 percentage points from 28.55% a year earlier. 38.15% of promoter shares were pledged. It had 93,354 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 27.35% | 25.84% | 25.82% | 25.80% | 26.78% | 28.26% | 28.26% | 27.82% | 27.82% | 27.87% | 27.87% | 28.96% |
| FIIs | 19.49% | 24.61% | 26.75% | 30.12% | 28.52% | 28.36% | 28.06% | 28.55% | 29.56% | 28.72% | 28.44% | 28.02% |
| DIIs | 19.00% | 17.64% | 18.15% | 18.22% | 16.90% | 13.70% | 13.28% | 12.96% | 13.00% | 14.42% | 15.40% | 15.49% |
| Government | 0.39% | 0.39% | 0.39% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 33.77% | 31.52% | 28.89% | 25.85% | 27.79% | 29.67% | 30.39% | 30.66% | 29.61% | 28.98% | 28.28% | 27.52% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 38.15% |
| Number of shareholders | 91,200 | 84,711 | 91,935 | 96,027 | 1,14,258 | 95,143 | 92,907 | 91,224 | 85,605 | 86,633 | 94,868 | 93,354 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Pronomz Ventures Llp | Promoter | 19.63% | 0.00 |
| Quant Mutual Fund - Quant Multi Cap Fund | DII | 6.14% | New |
| Route One Offshore Master Fund, L.P. | FII | 5.07% | 0.00 |
| Karuna Business Solutions Llp | Promoter | 3.48% | 0.00 |
| Sbi Life Insurance Co. Ltd | DII | 3.44% | −1.28 |
| Arun Kumar Pillai | Promoter | 3.08% | +1.08 |
| Bandhan Bse Healthcare Index Fund | DII | 2.80% | New |
| Route One Fund I, L.P. | FII | 2.16% | 0.00 |
| Satpal Khattar | Public | 1.59% | 0.00 |
| Abu Dhabi Investment Authority - Monsoon | FII | 1.47% | +0.13 |
| K R Ravishankar | Promoter | 1.35% | 0.00 |
| Authum Investment And Infrastructure Limited | Public | 1.35% | +0.06 |
| Mukul Mahavir Agrawal | Public | 1.13% | 0.00 |
| Oman India Joint Investment Fund Ii | DII | 1.09% | 0.00 |
| Vanguard Total International Stock Index Fund | FII | 1.02% | New |
| Ishares Core Msci Emerging Markets Etf | FII | 1.01% | −0.03 |
| Agraganya Private Trust (Trustee: Barclay Wealth Trustees (I) Pvt Ltd) | Promoter | 0.33% | 0.00 |
| Karuna Family Private Trust (Trustee: Barclay Wealth Trustees (I) Pvt Ltd) | Promoter | 0.23% | 0.00 |
| Vineetha Mohanakumar Pillai | Promoter | 0.21% | 0.00 |
| Padmakumar Karunakaran Pillai | Promoter | 0.20% | 0.00 |
| K R Lakshmi | Promoter | 0.14% | 0.00 |
| Sajitha Pillai | Promoter | 0.10% | 0.00 |
| Hemalatha Pillai | Promoter | 0.07% | 0.00 |
| Rajitha Gopalakrishnan | Promoter | 0.07% | 0.00 |
| Aditya Arun Kumar | Promoter | 0.06% | 0.00 |
Promoters held 28.96% of Strides Pharma Science at the end of the Sep 2026 quarter, up 1.14 percentage points from 27.82% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 28.02% (down 0.42 percentage points from 28.44% a quarter earlier) and domestic institutions (DIIs) held 15.49% (up 0.09 percentage points from 15.40% a quarter earlier).
Yes. 38.15% of promoter shares were pledged at the end of the Sep 2026 quarter.
Strides Pharma Science had 93,354 shareholders at the end of the Sep 2026 quarter, against 91,224 a year earlier.
Quant Mutual Fund - Quant Multi Cap Fund (DII) held 6.14% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.